Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
949 studies found for:    Open Studies | "Prostatic Diseases"
Show Display Options
Rank Status Study
1 Recruiting Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia, Benign;   Prostatic Hypertrophy, Benign;   Genital Diseases, Male;   Lower Urinary Tract Symptoms;   Prostatic Diseases
Interventions: Procedure: Prostatic Arterial Embolization;   Procedure: Sham procedure
2 Recruiting Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Genital Diseases, Male;   Prostatic Diseases
Intervention: Drug: EPI-506
3 Unknown  A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy
Conditions: Infection;   Prostatic Diseases;   Misadventure During Aspirating Needle Biopsy
Intervention: Drug: Povidone-Iodine
4 Recruiting MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Prostatic Diseases
Intervention:
5 Recruiting A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study
Condition: Castration-Resistant Prostate Cancer
Intervention: Drug: Apalutamide
6 Recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Interventions: Drug: onapristone;   Drug: abiraterone
7 Recruiting Radiotherapy vs Observation for CRPC
Condition: Hormone Refractory Prostate Cancer
Intervention:
8 Unknown  Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Biological: PEP-223/CoVaccine HT
9 Not yet recruiting Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC
Condition: Prostate Cancer Metastatic
Interventions: Drug: Apalutamide;   Drug: Abiraterone acetate;   Drug: Docetaxel;   Drug: Prednisone
10 Recruiting Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer
Condition: Prostate Cancer
Interventions: Device: Endorectal Balloon;   Device: Rectal Spacer;   Radiation: Radiation therapy
11 Recruiting Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy
Condition: Prostatic Cancer
Interventions: Drug: MIDAZOLAM;   Drug: MEPIVACAÍNE;   Drug: FENTANILE;   Drug: KETAMINE
12 Not yet recruiting Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer
Condition: Metastatic Castration-resistant Prostate Cancer (CRPCa)
Interventions: Other: neuropsychologic evaluation;   Other: oncogeriatric evaluation
13 Not yet recruiting A Study of the Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer
Condition: Prostatic Neoplasms, Castration-Resistant
Interventions: Drug: JNJ-809;   Drug: Apalutamide
14 Recruiting PACCT: Partnering Around Cancer Clinical Trials
Condition: Prostate Cancer
Interventions: Behavioral: Patients: Questions to Ask Your Doctor: A Workbook for Patient-Doctor Teams;   Behavioral: Physicians: Educational Module
15 Not yet recruiting Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Palbociclib
16 Not yet recruiting A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Condition: Prostatic Neoplasms
Intervention:
17 Not yet recruiting Neoadjuvant And Adjuvant Abiraterone Acetate + Aptilutamide Prostate Cancer Undergoing Prostatectomy
Condition: Prostate Cancer
Interventions: Drug: Aptilutamide;   Drug: Leuprolide;   Drug: Prednisone;   Drug: Abiraterone Acetate;   Procedure: Radical Prostatectomy;   Other: Observation-Post RP
18 Not yet recruiting Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)
Condition: Prostate Cancer
Interventions: Drug: Abiraterone acetate;   Drug: Prednisone;   Drug: Radium-223 dichloride;   Drug: cabazitaxel;   Drug: Carboplatin;   Drug: Enzalutamide
19 Recruiting Fundación IVO Registry for Patients Undergoing Sling or Artificial Urinary Sphincter After Prostate Cancer Treatment
Condition: Urinary Incontinence, Stress
Interventions: Procedure: AMS-800;   Procedure: ADVANCE/ADVANCEXP;   Procedure: VIRTUE;   Procedure: INVANCE
20 Not yet recruiting MED-C Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Conditions: Neoplasms;   Lung Neoplasms;   Colon Neoplasms;   Breast Neoplasms;   Pancreatic Neoplasms;   Prostate Neoplasms;   Kidney Neoplasms;   Liver Neoplasms;   Rectal Neoplasms;   Hematologic Neoplasms;   Multiple Myeloma;   Myelodysplastic Syndromes;   Ovarian Neoplasms;   Bladder Neoplasms;   Testicular Neoplasms;   Endometrial Neoplasms;   Brain Neoplasms;   Biliary Tract Neoplasms;   Head and Neck Neoplasms;   Uterine Cervical Neoplasms;   Skin Neoplasms;   Melanoma;   Gastric Neoplasms;   Anal Neoplasms;   Sarcoma
Intervention: Other: Provider determined

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years